[Possible alternative to the corticoid treatment of hyperandrogenic endocrine diseases with ovulation inhibitors].
D000324:Adrenocorticotropic Hormone / Q000009:adverse effects*; D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy; D000728:Androgens / Q000096:biosynthesis*; D004700:Endocrine System Diseases / Q000188:drug therapy*; D005260:Female; D006628:Hirsutism / Q000188:drug therapy; D006801:Humans; D008234:Lynestrenol / Q000627:therapeutic use*; D008656:Mestranol / Q000627:therapeutic use*; D011085:Polycystic Ovary Syndrome / Q000188:drug therapy
D000728:Androgens; D000324:Adrenocorticotropic Hormone; D008656:Mestranol; D008234:Lynestrenol
Possibile alternativa al trattamento cortisonico in alcune disendocrinie iperandrogeniche con gli inibitori dell'ovulazione.